Abstract
Abstract
Gallbladder cancer (GBC) is a rare malignancy worldwide, with 140,000 new patients each year and more than 100,000 deaths annually. The review aims to address the controversial aspects of managing GBC. Regional differences of the study worldwide remain pending, and comparative mutational profiles will provide more information on the pathogenesis of GBC. However, certain pathologic aspects are discussed, such as the staging of early GBC, outcome differences between T2 pathologically staged patients, and the necessity of a uniform pathologic report. The surgical management of GBC is still under debate. The extent of liver resection, type of lymphadenectomy, and selection of patients for extended resection are aspects of the disease that require revision. Laparoscopic and robotic approaches were initially slow to develop. However, with time, they have demonstrated their value in the surgical management of GBC. The OMEGA survey, performed to analyze the management practice of surgical treatment of GBC worldwide, demonstrated differences from the recommended guidelines. The OMEGA study, the largest cohort study, examined the outcomes of surgical intervention in 3676 patients from 133 centers. Regarding future directions, the value of collaborative efforts between centers and regions must be emphasized to better understand the different aspects of the disease and globally improve therapeutic strategies for GBC.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference58 articles.
1. Worldwide distribution, associated factors, and trends of gallbladder cancer: a global country-level analysis;Cancer Lett,2021
2. Gallbladder and extrahepatic bile duct cancers in the Americas: incidence and mortality patterns and trends;Int J Cancer,2020
3. Gallbladder cancer: South American experience;Chin Clin Oncol,2016
4. Palliative treatment for locally advanced or metastatic gallbladder cancer: conclusions of the Latin American Consensus Meeting for the Management of Gallbladder Cancer;Rev Med Chil,2011
5. Subtypes of native American ancestry and leading causes of death: Mapuche ancestry–specific associations with gallbladder cancer risk in Chile;PLoS Genet,2017